FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lourdes Ibáñez

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Physiology

Concepts & Ideas

Procedures

Drug Therapy, Combination

Co-author Network

Publications

TOP 3
Lourdes Ibáñez; Abel López-Bermejo; Maria Victoria Marcos; Giorgia Sebastiani; Marta Díaz; Francis de Zegher
Oral Contraception vs Insulin Sensitization for 18 Months in Nonobese Adolescents With Androgen Excess: Posttreatment Differences in C-Reactive Protein, Intima-Media Thickness, Visceral Adiposity, Insulin Sensitivity, and Menstrual Regularity.
Francis de Zegher; Marta Diaz; María Dolores Gómez-Roig; Abel López-Bermejo; Giorgia Sebastiani; Lourdes Ibáñez
Breast-feeding vs formula-feeding for infants born small-for-gestational-age: divergent effects on fat mass and on circulating IGF-I and high-molecular-weight adiponectin in late infancy.
Marta Díaz; Matilde R Chacón; Francis de Zegher; Abel López-Bermejo; Elsa Maymó-Masip; Cristina Salvador; Joan Vendrell; Lourdes Ibáñez
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lourdes Ibáñez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lourdes Ibáñez; Abel López-Bermejo; Maria Victoria Marcos; Giorgia Sebastiani; Marta Díaz; Francis de Zegher
Oral Contraception vs Insulin Sensitization for 18 Months in Nonobese Adolescents With Androgen Excess: Posttreatment Differences in C-Reactive Protein, Intima-Media Thickness, Visceral Adiposity, Insulin Sensitivity, and Menstrual Regularity.
The Journal of clinical endocrinology and metabolism 2013;98(5):E902-7.
2013: Francis de Zegher; Marta Diaz; María Dolores Gómez-Roig; Abel López-Bermejo; Giorgia Sebastiani; Lourdes Ibáñez
Breast-feeding vs formula-feeding for infants born small-for-gestational-age: divergent effects on fat mass and on circulating IGF-I and high-molecular-weight adiponectin in late infancy.
The Journal of clinical endocrinology and metabolism 2013;98(3):1242-7.
2012: Marta Díaz; Matilde R Chacón; Francis de Zegher; Abel López-Bermejo; Elsa Maymó-Masip; Cristina Salvador; Joan Vendrell; Lourdes Ibáñez
Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
The Journal of clinical endocrinology and metabolism 2012;97(10):3630-8.
2012: Marta Díaz; Maria Dolores Gómez-Roig; Judit Bassols; Francis de Zegher; Abel López-Bermejo; Lourdes Ibáñez
Placental expression of peroxisome proliferator-activated receptor γ (PPARγ): relation to placental and fetal growth.
The Journal of clinical endocrinology and metabolism 2012;97(8):E1468-72.
2012: G Sebastiani; Abel López-Bermejo; A Arranz; Francis de Zegher; M Díaz; Lourdes Ibáñez
Circulating follistatin in the human foetus at term birth.
Pediatric obesity 2012;7(1):39-43.
2012: Silvia Marín; Belén Pérez-Dueñas; Sergio Pinillos; Ron G Rosenfeld; Giorgia Sebastiani; Nancy Villarreal-Peña; Paula Casano-Sancho; Vivian Hwa; Lourdes Ibáñez
Triple A syndrome in a patient with genetic growth hormone insensitivity: phenotypic effects of two genetic disorders.
Hormone research in pædiatrics 2012;77(1):63-8.
2011: David Sánchez-Infantes; Francis de Zegher; Marta Díaz; Abel López-Bermejo; Maria Victoria Marcos; Lourdes Ibáñez
Pharmacokinetics of metformin in girls aged 9 years.
Clinical pharmacokinetics 2011;50(11):735-8.
2011: Lourdes Ibáñez; Abel Lopez-Bermejo; Cristina Salvador; David Sánchez-Infantes; Giorgia Sebastiani; Marta Diaz; Francis de Zegher
Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
The Journal of clinical endocrinology and metabolism 2011;96(11):3361-6.
2011: Lourdes Ibáñez; Abel López-Bermejo; Maria Victoria Marcos; Marta Díaz; Francis de Zegher
Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.
The Journal of clinical endocrinology and metabolism 2011;96(8):E1262-7.
2011: Marta Díaz; Judit Bassols; Francis de Zegher; Abel López-Bermejo; David Sánchez-Infantes; Lourdes Ibáñez
Responsiveness to metformin in girls with androgen excess: collective influence of genetic polymorphisms.
Fertility and sterility 2011;96(1):208-213.e2.
2011: Lourdes Ibáñez; Abel Lopez-Bermejo; Marta Diaz; Francis de Zegher
Catch-up growth in girls born small for gestational age precedes childhood progression to high adiposity.
Fertility and sterility 2011;96(1):220-3.
2011: Lourdes Ibáñez; Abel Lopez-Bermejo; Marta Diaz; Maria Victoria Marcos; Francis de Zegher
Early metformin therapy to delay menarche and augment height in girls with precocious pubarche.
Fertility and sterility 2011;95(2):727-30.
2010: Marta Díaz; Abel López-Bermejo; Clive J Petry; Francis de Zegher; Lourdes Ibáñez
Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone-binding globulin and androgen receptor polymorphisms.
Fertility and sterility 2010;94(7):2800-3.e1.
2010: Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Goya Enríquez; Luis Del Río; Francis de Zegher
Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2010;26(12):869-73.
2010: Lourdes Ibáñez; Abel Lopez-Bermejo; Marta Díaz; Adriana Jaramillo; Silvia Marín; Francis de Zegher
Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin.
The Journal of clinical endocrinology and metabolism 2010;95(5):2234-9.
2010: Lourdes Ibáñez; Giorgia Sebastiani; Marta Diaz; Maria Dolores Gómez-Roig; Abel Lopez-Bermejo; Francis de Zegher
Low body adiposity and high leptinemia in breast-fed infants born small-for-gestational-age.
The Journal of pediatrics 2010;156(1):145-7.
2010: Lourdes Ibáñez; Abel Lopez-Bermejo; Marta Diaz; Maria Victoria Marcos; Francis de Zegher
Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity.
The Journal of pediatrics 2010;156(1):98-102.e1.
2009: Lourdes Ibáñez; Abel Lopez-Bermejo; Marta Diaz; Mario Angulo; Giorgia Sebastiani; Francis de Zegher
High-molecular-weight adiponectin in children born small- or appropriate-for-gestational-age.
The Journal of pediatrics 2009;155(5):740-2.
2009: Lourdes Ibáñez; Abel Lopez-Bermejo; Marta Díaz; Larisa Suárez; Francis de Zegher
Low-birth weight children develop lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their visceral adiposity and hypoadiponectinemia between six and eight years of age.
The Journal of clinical endocrinology and metabolism 2009;94(10):3696-9.
2009: Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Goya Enríquez; Luis del Río; Francis de Zegher
Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.
Clinical endocrinology 2009;71(3):351-7.
2009: Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Maria Victoria Marcos; Paula Casano; Francis de Zegher
Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age.
The Journal of clinical endocrinology and metabolism 2009;94(3):1049-52.
2009: Lourdes Ibáñez; Rubén Díaz; Abel López-Bermejo; Maria Victoria Marcos
Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism.
Reviews in endocrine & metabolic disorders 2009;10(1):63-76.
2008: Lourdes Ibáñez; Giorgia Sebastiani; Abel Lopez-Bermejo; Marta Díaz; Maria Dolores Gómez-Roig; Francis de Zegher
Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth.
The Journal of clinical endocrinology and metabolism 2008;93(7):2774-8.
2008: Lourdes Ibáñez; Abel Lopez-Bermejo; Larisa Suárez; Maria Victoria Marcos; Marta Díaz; Francis de Zegher
Visceral adiposity without overweight in children born small for gestational age.
The Journal of clinical endocrinology and metabolism 2008;93(6):2079-83.
2008: Lourdes Ibáñez; Abel López-Bermejo; Francis de Zegher
Pubertal adiposity after fetal growth restraint: toward a calorie restriction mimetic approach.
Metabolism: clinical and experimental 2008;57(5):672-5.
2008: Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Maria Victoria Marcos; Francis de Zegher
Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.
The Journal of clinical endocrinology and metabolism 2008;93(5):1841-5.
2008: Lourdes Ibáñez; Larisa Suárez; Abel Lopez-Bermejo; Marta Díaz; Carme Valls; Francis de Zegher
Early development of visceral fat excess after spontaneous catch-up growth in children with low birth weight.
The Journal of clinical endocrinology and metabolism 2008;93(3):925-8.
2008: Lourdes Ibáñez; Abel López-Bermejo; Marta Díaz; Goya Enríquez; Carme Valls; Francis de Zegher
Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.
Clinical endocrinology 2008;68(2):317-20.
2008: Lourdes Ibáñez; Abel López-Bermejo; Justo Callejo; Ana Torres; Sergi Cabré; David D Dunger; Francis de Zegher
Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth.
The Journal of clinical endocrinology and metabolism 2008;93(1):196-9.
2007: Lourdes Ibáñez; Abel López-Bermejo; Luis del Rio; Goya Enríquez; Carme Valls; Francis de Zegher
Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
The Journal of clinical endocrinology and metabolism 2007;92(5):1710-4.
2007: Lourdes Ibáñez; Adriana Maria Jaramillo; Goya Enríquez; Elisabet Miró; Abel López-Bermejo; David D Dunger; Francis de Zegher
Polycystic ovaries after precocious pubarche: relation to prenatal growth.
Human reproduction (Oxford, England) 2007;22(2):395-400.
2006: Lourdes Ibáñez; Ken Ong; Carme Valls; Maria Victoria Marcos; David D Dunger; Francis de Zegher
Metformin treatment to prevent early puberty in girls with precocious pubarche.
The Journal of clinical endocrinology and metabolism 2006;91(8):2888-91.
2006: Lourdes Ibáñez; Francis de Zegher
Puberty and prenatal growth.
Molecular and cellular endocrinology 2006;254-255():22-5.
2006: Lourdes Ibáñez; Francis de Zegher
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
Fertility and sterility 2006;86 Suppl 1():S24-5.
2006: Lourdes Ibáñez; Ken Ong; David D Dunger; Francis de Zegher
Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children.
The Journal of clinical endocrinology and metabolism 2006;91(6):2153-8.
2006: Lourdes Ibáñez; Carme Valls; Ken Ong; David D Dunger; Francis de Zegher
Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: a randomized study in low-birth-weight girls with early-normal onset of puberty.
The Journal of clinical endocrinology and metabolism 2006;91(6):2068-73.
2006: Lourdes Ibáñez; Francis de Zegher
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
Human reproduction update 2006;12(3):243-52.
2006: Lourdes Ibáñez; Carme Valls; Francis de Zegher
Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.
Human reproduction (Oxford, England) 2006;21(2):451-6.
2006: Lourdes Ibáñez; Francis de Zegher
Puberty after prenatal growth restraint.
Hormone research 2006;65 Suppl 3():112-5.
2006: Lourdes Ibáñez; Rafael Jiménez; Francis de Zegher
Early puberty-menarche after precocious pubarche: relation to prenatal growth.
Pediatrics 2006;117(1):117-21.
2005: Lourdes Ibáñez; Angela Ferrer; Maria Victoria Marcos
Hyperandrogenism and excess weight gain.
Journal of pediatric endocrinology & metabolism : JPEM 2005;18 Suppl 1():1199-205.
2005: Lourdes Ibáñez; Adriana Maria Jaramillo; Angela Ferrer; Francis de Zegher
High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
Human reproduction (Oxford, England) 2005;20(9):2457-62.
2005: Lourdes Ibáñez; Adriana Maria Jaramillo; Angela Ferrer; Francis de Zegher
Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
Human reproduction (Oxford, England) 2005;20(7):1833-6.
2005: Lourdes Ibáñez; Alina Fucci; Carme Valls; Ken Ong; David D Dunger; Francis de Zegher
Neutrophil count in small-for-gestational age children: contrasting effects of metformin and growth hormone therapy.
The Journal of clinical endocrinology and metabolism 2005;90(6):3435-9.
2005: Lourdes Ibáñez; Francis de Zegher
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
The Journal of clinical endocrinology and metabolism 2005;90(1):39-43.
2004: Lourdes Ibáñez; Carme Valls; Sergi Cabré; Francis de Zegher
Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.
The Journal of clinical endocrinology and metabolism 2004;89(9):4716-20.
2004: Lourdes Ibáñez; Carme Valls; Maria Victoria Marcos; Ken Ong; David D Dunger; Francis de Zegher
Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
The Journal of clinical endocrinology and metabolism 2004;89(9):4331-7.
2004: Lourdes Ibáñez; Francis de Zegher
Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
Human reproduction (Oxford, England) 2004;19(8):1725-7.
2004: Lourdes Ibáñez; Francis de Zegher
Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
The Journal of clinical endocrinology and metabolism 2004;89(4):1592-7.
2004: Lourdes Ibáñez; Angela Ferrer; Ken Ong; Rakesh Amin; David D Dunger; Francis de Zegher
Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
The Journal of pediatrics 2004;144(1):23-9.
2003: Lourdes Ibáñez; Francis de Zegher
Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
The Journal of clinical endocrinology and metabolism 2003;88(10):4720-4.
2003: Lourdes Ibáñez; Neus Potau; Goya Enriquez; Maria Victoria Marcos; Francis de Zegher
Hypergonadotrophinaemia with reduced uterine and ovarian size in women born small-for-gestational-age.
Human reproduction (Oxford, England) 2003;18(8):1565-9.
2003: Lourdes Ibáñez; Ken K Ong; Nigel P Mongan; Jarmo Jääskeläinen; Maria Victoria Marcos; Ieuan A Hughes; Francis de Zegher; David D Dunger
Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism.
The Journal of clinical endocrinology and metabolism 2003;88(7):3333-8.
2003: Lourdes Ibáñez; Ken Ong; Angela Ferrer; Rakesh Amin; David D Dunger; Francis de Zegher
Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
The Journal of clinical endocrinology and metabolism 2003;88(6):2600-6.
2003: Lourdes Ibáñez; Ken Ong; Francis de Zegher; Maria Victoria Marcos; Luis del Rio; David D Dunger
Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.
Clinical endocrinology 2003;58(3):372-9.
2003: Lourdes Ibáñez; Francis de Zegher
Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome.
Human reproduction (Oxford, England) 2003;18(1):57-60.
2002: Lourdes Ibáñez; Maria Victoria Marcos; Neus Potau; Carlie White; Christopher E Aston; Selma F Witchel
Increased frequency of the G972R variant of the insulin receptor substrate-1 (irs-1) gene among girls with a history of precocious pubarche.
Fertility and sterility 2002;78(6):1288-93.
2002: Lourdes Ibáñez; Neus Potau; Angela Ferrer; Francisco Rodriguez-Hierro; Maria Victoria Marcos; Francis de Zegher
Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism.
The Journal of clinical endocrinology and metabolism 2002;87(12):5702-5.
2002: Lourdes Ibáñez; Neus Potau; Angela Ferrer; Francisco Rodriguez-Hierro; Maria Victoria Marcos; Francis de Zegher
Reduced ovulation rate in adolescent girls born small for gestational age.
The Journal of clinical endocrinology and metabolism 2002;87(7):3391-3.
2002: Lourdes Ibáñez; Carme Valls; Angela Ferrer; Ken Ong; David D Dunger; Francis de Zegher
Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
The Journal of clinical endocrinology and metabolism 2002;87(6):2870-4.
2002: Lourdes Ibáñez; Carme Valls; Maria Cols; Angela Ferrer; Maria Victoria Marcos; Francis de Zegher
Hypersecretion of FSH in infant boys and girls born small for gestational age.
The Journal of clinical endocrinology and metabolism 2002;87(5):1986-8.
2002: Lourdes Ibáñez; Carme Valls; Elisabet Miró; Maria Victoria Marcos; Francis de Zegher
Early menarche and subclinical ovarian hyperandrogenism in girls with reduced adult height after low birth weight.
Journal of pediatric endocrinology & metabolism : JPEM 2002;15(4):431-3.
2002: Lourdes Ibáñez; Carles Aulesa; Neus Potau; Ken Ong; David D Dunger; Francis de Zegher
Plasminogen activator inhibitor-1 in girls with precocious pubarche: a premenarcheal marker for polycystic ovary syndrome?
Pediatric research 2002;51(2):244-8.
2002: Maria Victoria Marcos; Lourdes Ibáñez; Carme Valls; Neus Potau; Francisco Rodriguez-Hierro; Zegher Francis de
Rapid corticotropin versus corticotropin-releasing hormone test in girls with precocious pubarche.
Journal of pediatric endocrinology & metabolism : JPEM 2002;15(1):89-91.
2001: Lourdes Ibáñez; Ken Ong; Neus Potau; Maria Victoria Marcos; Francis de Zegher; David D Dunger
Insulin gene variable number of tandem repeat genotype and the low birth weight, precocious pubarche, and hyperinsulinism sequence.
The Journal of clinical endocrinology and metabolism 2001;86(12):5788-93.
2001: Lourdes Ibáñez; Carme Valls; Neus Potau; Maria Victoria Marcos; Francis de Zegher
Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.
Clinical endocrinology 2001;55(5):667-72.
2001: Lourdes Ibáñez; Carme Valls; Angela Ferrer; Maria Victoria Marcos; Francisco Rodriguez-Hierro; Francis de Zegher
Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.
The Journal of clinical endocrinology and metabolism 2001;86(8):3595-8.
2000: Lourdes Ibáñez; Joan DiMartino-Nardi; Neus Potau; Paul Saenger
Premature adrenarche--normal variant or forerunner of adult disease?
Endocrine reviews 2000;21(6):671-96.
2000: Lourdes Ibáñez; Angela Ferrer; Maria Victoria Marcos; F R Hierro; Francis de Zegher
Early puberty: rapid progression and reduced final height in girls with low birth weight.
Pediatrics 2000;106(5):E72.
2000: Lourdes Ibáñez; Carme Valls; Neus Potau; Maria Victoria Marcos; Francis de Zegher
Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
The Journal of clinical endocrinology and metabolism 2000;85(10):3526-30.
2000: Lourdes Ibáñez; Neus Potau; Maria Victoria Marcos; Francis de Zegher
Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche.
Clinical endocrinology 2000;53(4):523-7.
2000: Lourdes Ibáñez; Neus Potau; Maria Victoria Marcos; Francis de Zegher
Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.
The Journal of clinical endocrinology and metabolism 2000;85(9):3251-5.
2000: Lourdes Ibáñez; Neus Potau; Francis de Zegher
Ovarian hyporesponsiveness to follicle stimulating hormone in adolescent girls born small for gestational age.
The Journal of clinical endocrinology and metabolism 2000;85(7):2624-6.
2000: Lourdes Ibáñez; Neus Potau; Francis de Zegher
Recognition of a new association: reduced fetal growth, precocious pubarche, hyperinsulinism and ovarian dysfunction.
Annales d'endocrinologie 2000;61(2):141-2.
2000: Lourdes Ibáñez; Neus Potau; G Enriquez; Francis de Zegher
Reduced uterine and ovarian size in adolescent girls born small for gestational age.
Pediatric research 2000;47(5):575-7.
2000: S Rique; Lourdes Ibáñez; Maria Victoria Marcos; Antonio Carrascosa; Neus Potau
Effects of metformin on androgens and insulin concentrations in type A insulin resistance syndrome.
Diabetologia 2000;43(3):385-6.
2000: Lourdes Ibáñez; Neus Potau; Ken Ong; David D Dunger; Francis de Zegher
Increased bone mineral density and serum leptin in non-obese girls with precocious pubarche: relation to low birthweight and hyperinsulinism.
Hormone research 2000;54(4):192-7.
2000: Lourdes Ibáñez; Neus Potau; David D Dunger; Francis de Zegher
Precocious pubarche in girls and the development of androgen excess.
Journal of pediatric endocrinology & metabolism : JPEM 2000;13 Suppl 5():1261-3.
1999: Lourdes Ibáñez; Neus Potau; Francis de Zegher
Endocrinology and metabolism after premature pubarche in girls.
Acta paediatrica (Oslo, Norway : 1992). Supplement 1999;88(433):73-7.
1999: Lourdes Ibáñez; Neus Potau; Maria Victoria Marcos; Francis de Zegher
Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age.
The Journal of clinical endocrinology and metabolism 1999;84(12):4739-41.
1999: Lourdes Ibáñez; Neus Potau; Maria Victoria Marcos; Francis de Zegher
Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
The Journal of clinical endocrinology and metabolism 1999;84(12):4602-6.
1999: Lourdes Ibáñez; Conxa Castell; Ricard Tresserras; Neus Potau
Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche.
Clinical endocrinology 1999;51(4):395-401.
1999: Lourdes Ibáñez; Neus Potau; Maria Victoria Marcos; Francis de Zegher
Corticotropin-releasing hormone as adrenal androgen secretagogue.
Pediatric research 1999;46(3):351-3.
1999: Lourdes Ibáñez; Francis de Zegher; Neus Potau
Anovulation after precocious pubarche: early markers and time course in adolescence.
The Journal of clinical endocrinology and metabolism 1999;84(8):2691-5.
1999: Neus Potau; Lourdes Ibáñez; M Sentis; Antonio Carrascosa
Sexual dimorphism in the maturation of the pituitary-gonadal axis, assessed by GnRH agonist challenge.
European journal of endocrinology / European Federation of Endocrine Societies 1999;141(1):27-34.